Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17

Showing 17 citing articles:

Vaccination of Adults With Cancer: ASCO Guideline
Mini Kamboj, Kari Bohlke, Deana M. Baptiste, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1699-1721
Closed Access | Times Cited: 17
“It's a risk-benefit analysis”: Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia
Holly Chung, Meinir Krishnasamy, Trish Joyce, et al.
Vaccine (2025) Vol. 50, pp. 126826-126826
Closed Access
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102040-102040
Open Access | Times Cited: 12
COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
Victoria Hall, Benjamin W. Teh
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S55-S69
Open Access | Times Cited: 11
Vaccinations in patients with chronic lymphocytic leukemia
Elizabeth R. Francis, Jennifer Vu, Catherine ostos Perez, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 2, pp. 131-138
Closed Access | Times Cited: 3
Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis
Leyla Sharifi Aliabadi, Mojtaba Azari, Mohammad Reza Taherian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin’s Lymphoma: A Single-Center Cohort Study
Makoto Saito, Akio Mori, Takashi Ishio, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 328-328
Open Access | Times Cited: 2
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5624-5636
Open Access | Times Cited: 3
SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study
Diego R. Hijano, Jose Ferrolino, Elizabeth Swift, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients
Jong Eun Lee, Jin Woo Kim, Minhee Hwang, et al.
Korean Journal of Radiology (2024) Vol. 25, Iss. 5, pp. 481-481
Open Access
Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States
Ana Carolina Mourão Toreli, Marisol Miranda Galvis, Muhannad Sharara, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 11, pp. 1706-1715
Open Access
COVID-19 vaccination in patients with classic and variant hairy cell leukemia
Robert J. Kreitman, Lacey James, Julie Feurtado, et al.
Deleted Journal (2024) Vol. 1, Iss. 4, pp. 100035-100035
Open Access
Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination
Ksenia V. Zornikova, Nataliia O Ivanova, O. A. Aleshina, et al.
Russian journal of hematology and transfusiology (2024) Vol. 69, Iss. 2, pp. 200-216
Open Access
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 1
Response Rate to the 3rd and 4th Doses of BNT162b2 Vaccine in Cancer Patients Administered with Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
(2023)
Open Access | Times Cited: 1
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, et al.
Diseases (2023) Vol. 11, Iss. 4, pp. 128-128
Open Access | Times Cited: 1
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies
Chien-Tzu Huang, Ching-Ping Lee, Tzu‐Yin Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5647-5647
Open Access
Page 1

Scroll to top